---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020750"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:39:35.250893+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics 2025 annual meeting elects directors, approves equity plan amendment, ratifies auditor

## Summary
- All six director nominees elected: Huntsman, Green, Krammer, Lindsay, Sokolow, Thompson; each with >2.6M votes for.
- Amendment to 2024 Omnibus Equity Incentive Plan approved with 2.45M for, 516K against, 2.3K abstain.
- Appointment of Baker Tilly US, LLP as auditor for FY ending Dec 31, 2025 ratified with 4.86M for.

## SEC filing metadata
- accession: 0001493152-25-020750
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315225020750/0001493152-25-020750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315225020750/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020750
- JSON: https://secwatch.observer/filing/0001493152-25-020750.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.